Following President Trump’s meeting with President Xi Jinping in Busan, the White House has now officially published an Executive Order confirming the tariff adjustments outlined in the recent U.S.–China economic arrangement.

Here’s what’s now official:

  • The Executive Order “Modifying Reciprocal Tariff Rates” formally reduces the fentanyl-related tariff rate from 20% to 10%, effective November 10, 2025.
  • The U.S. will maintain a 10% reciprocal tariff on Chinese imports while suspending further increases until November 10, 2026.
  • Section 301 tariff exclusions have been extended through November 2026, providing importers continued relief.

In return, China has confirmed key commitments under the same arrangement:

  • Suspension of export restrictions on rare-earth minerals, gallium, germanium, graphite, and other critical inputs used in U.S. manufacturing.
  • Resumption of large-scale purchases of U.S. agricultural goods (including soybeans, sorghum, and hardwood logs).
  • Removal of retaliatory tariffs and sanctions targeting U.S. agricultural, logistics, and semiconductor sectors.
  • Continued diplomatic engagement, with President Trump set to visit China in April 2026 and President Xi expected to visit the U.S. later next year.

Both sides also confirmed the suspension of planned reciprocal port fees while negotiations continue on a broader maritime and logistics framework.

What does this mean for me?

For shipments arriving into the United States on or after November 10, the IEEPA Fentanyl 20% tariff will be reduced to 10%.  All other tariffs specific to China will remain in place; meaning the reciprocal tariff rate will remain at 10% and all applicable Section 301 duties will remain in place.  Any Section 301 exclusions still active have been extended to November 2026.  

We’ll continue to monitor implementation details from USTR and CBP and share updates as they are released.